Follow us on:
Breaking News
July 15, 2026
CP Direct: Wednesday Edition
Breaking News
Editor's Pick: Pharma Matters Podcast
NelsonLabs_Podcast_0626_FeaturedContent

Cytovance Adds Perfusion Capabilities

 
Cytovance Adds Perfusion Capabilities

New capabilities give biologics sponsors more flexibility in upstream process development.
Read More >>

Top Headlines

Breaking News

Bruker Acquires DISQVER Clinical Metagenomics Platform

Expands its next-generation sequencing-based infection detection capabilities.

SPONSOR

Reducing Risk and Quality Cost in Supplier Qualification

In this Contract Pharma webinar on July 16, learn proven strategies to streamline supplier audits, reduce quality spend, and keep your supply chain compliant. Registration is open!

Breaking News
Collaborations & Alliances

Bora, Insilico Launch Multi-Target AI Pharma Alliance

Strategic alliance combines Insilico’s Pharma.AI platform with Bora’s development, manufacturing and commercialization capabilities.

Breaking News
Collaborations & Alliances

BriaCell Taps FUJIFILM for Bria-IMT Manufacturing

Deal supports Phase 3 development and potential commercial supply of breast cancer cell therapy.

SPONSOR

From Capacity to Coordination: The Hidden Bottleneck in Scaling CGT

As CGT programs move toward scale, the bigger challenge is no longer capacity alone, but keeping the full supply chain aligned across sites, vendors, and handoffs.

GlC_ENL_071526_650x250

Breaking News
Promotions & Moves

Elevara Medicines Appoints Dr. Mai-Britt Zocca as CEO

Zocca offers extensive operational and strategic experience in the international biotechnology sector.

Online Exclusives

Single-Use Becomes the CGT Baseline

Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.

Featured Resources

Solution Content Center SPOTLIGHT

Thermo Fisher Scientific Pharma Services

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development and manufacturing organization (CDMO) and clinical services partner. Thermo Fisher’s end-to-end, integrated CDMO capabilities help companies on their drug development and manufacturing journeys. From research and development to regulatory landscape support, supply chain management, and everywhere in between, the company’s services and solutions support the entire life cycle of drug substances and drug products, from preclinical research to commercial manufacturing. Thermo Fisher knows your challenges and has developed solutions you can trust to help bring your treatment to market faster.

 

Solution Content Center SPOTLIGHT

Ropack Pharma Solutions

Ropack Pharma Solutions, celebrating 50 years, specializes in solid oral dose formats for pharmaceutical, nutraceutical, and food products. We provide comprehensive manufacturing, packaging, and clinical trial services, delivering trusted, innovative solutions that help our partners bring key products to market.